Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Daily deal net: February 24, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.


Feb 24, 2021

Shield AI screens $90m series C

Point72 Ventures has led a $90m series C round for Shield AI, whose leadership includes Carnegie Mellon University’s associate research professor Nathan Michael.

Feb 24, 2021

Xylowatt runs out of steam

UCLouvain spinout Xylowatt has declared bankruptcy after failing to build a market for its technology to convert biomass into energy.

Feb 24, 2021

Daily deal net: February 23, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 23, 2021

Azeria reaches the end of the line

Azeria Therapeutics has wound down voluntarily four years after being set up to advance University of Cambridge and Cancer Research UK work.

Feb 23, 2021

Nearpod approaches Renaissance Holding

Stanford-StartX Fund-backed Nearpod has agreed to an acquisition by Renaissance Holding.

Feb 23, 2021

Boreal begins with $20m fund

Boreal Ventures will invest in deep tech companies emerging from ÉTS Montréal’s incubator Centech and the wider Quebec ecosystem.

Feb 23, 2021

POI-Tech picks up $15.5m

South China University of Technology spinout POI-Tech is working on industrial internet applications and will use some of the money to expand R&D activities.

Feb 23, 2021

Centessa circles $250m series A

Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.

Feb 23, 2021

Artesian activates $79m fund

The firm has launched a fund and accelerator called Boab AI that will be run by Deakin University’s former ventures director Andrew Lai.

Feb 23, 2021

Elicio elevates series B to $73m

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

Feb 22, 2021

ImmuneID tackles $17m round

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

Feb 22, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here